isn frontiers logo 01

THIN 1200x168 3 02

Other sessions

  

Thursday, February 22 Eminence Hall
19:30-21:00

 

Welcome reception

 

Friday, February 23 Eminence Hall
Nishiki Room Hana Room Concord Ballroom A
8:00-8:55 8:00-9:00  

Morning seminar
(sponsored)

Diagnosis and treatment of atypical hemolytic uremic syndrome (aHUS)

Speaker: Shoichi Maruyama (Japan)

Chair: Yoshihiko Kanno (Japan)

(co-sponsored by Alexion)

Meet the Professor 1 (round-table discussion)
9:10-10:30

Young Investigator Network Session

1. miR-146a targeting the splenic macrophages prevents sepsis-induced acute kidney injury

With: Yoshio Funahashi (Japan)

 

2. Magnesium and the risk of fatal myocardial infarction in patients undergoing hemodialysis

With: Yusuke Sakaguchi (Japan)

 

3. Protective role of DJ-1 (PARK7) deficiency in sepsis-associated acute kidney injury

With: Joseph Leeds (USA)

 

4. The transcription factor MafB is essential for the maintenance of podocytes

With: Toshiaki Usui (Japan)

 

5. Ejection fraction as a predictor of survival among elderly patients with ESRD initiating maintenance hemodialysis

With: Matthew R D’Costa (USA)

 

6. Neural transcription factor Pou4f1 is essential for macrophage- myofibroblast transition driven kidney fibrosis

With: Patrick Ming-Kuen Tang (Hong Kong)

 

7. The association of RAAS blockade and the progression of residual kidney Function Decline: A nation-wide prospective cohort study

With: Kyung Don Yoo (Korea)

 

8. Rituximab improves cytoskeletal remodeling of podocytes induced by interleukin-13

With: Yuno Takahashi (Japan)

 

12:25-13:20

Luncheon seminar
(sponsored)

Reno-skeletal syndrome

Speaker: Junichiro James Kazama (Japan)

Chair: Ryo Okazaki (Japan)

(co-sponsored by Astellas Pharma Inc.)

Luncheon seminar
(sponsored)

Iron in the era of HIF stabilizers

Speaker: Takayuki Hamano (Japan)

Chair: Hirokazu Okada (Japan)

(co-sponsored by Torii Pharmaceutical Co., Ltd.)

16:40-17:35

Evening seminar
(sponsored)

Aldosterone, hypertension and the kidney: recent advances

Speaker: Shigeru Shibata (Japan)

Chair: Ichiei Narita (Japan)

(co-sponsored by Mochida Pharmaceutical Co., LTD. / EA Pharma Co.,Ltd.)

Evening seminar
(sponsored)

Current status of chronic kidney disease in Korea; how to overcome the unmet need in CKD

Speaker: Yon Su Kim (Korea)

Chair: Tadao Akizawa (Japan)

(co-sponsored by Kureha Corporation / Mitsubishi Tanabe Pharma Corporation)

17:45-18:45

Poster Session 1 /
Young Investigator Mixer Reception

 

Saturday, February 24 Eminence Hall
Nishiki Room Hana Room Concord Ballroom A
8:00-8:55 8:00-9:00  

Morning seminar
(sponsored)

Application of AI/ICT technology to kidney disease management

Speaker: Yoshitaka Isaka (Japan)

Chair: Takashi Shigematsu (Japan)

(co-sponsored by NIKKISO)

Meet the Professor 2 (round-table discussion)
12:20-13:15

Luncheon seminar
(sponsored)

Vascular calcification in chronic kidney disease: different bricks in the wall?

Speaker: Masafumi Fukagawa (Japan)

Chair: Masafumi Fukagawa (Japan)

(co-sponsored by Bayer Yakuhin, Ltd.)

Luncheon seminar
(sponsored)

Protein-energy wasting and frailty in chronic kidney disease

Speaker: Joel D. Kopple (USA)

Chair: Takao Masaki (Japan)

(co-sponsored by Chugai Pharmaceutical CO., LTD.)

16:35-17:30

Evening seminar
(sponsored)

ADPKD update

Tolvaptan for ADPKD; The latest clinical evidence and Japan's post-launch experience

Speaker: Saori Nishio (Japan)

Modeling polycystic kidney disease using iPS cells

Speaker: Kenji Osafune (Japan)

Chair: Takashi Yokoo (Japan)

(co-sponsored by Otsuka Pharmaceutical Co., Ltd.)

Evening seminar
(sponsored)

Recent advances in Fabry Disease

Cardiac involvement and the role of enzyme replacement therapy in Japanese Fabry patients

Speaker: Kenichi Hongo (Japan)

Screening of Fabry nephropathy in patients with CKD not on dialysis

Speaker: Kei Fukami (Japan)

Chair: Yukio Yuzawa (Japan)

(co-sponsored by Sumitomo Dainippon Pharma Co., Ltd.)

18:30-19:30

Poster Session 2

19:30-21:00

Award reception

 

Sunday, February 25 Nishiki Room Hana Room
8:05-9:00

Morning seminar
(sponsored)

Real-world treatment pattern of Japanese chronic kidney disease patients: A multicenter cohort study

Speaker: Daijo Inaguma (Japan)

Chair: Yusuke Suzuki (Japan)

(co-sponsored by Kyowa Hakko Kirin Co.,Ltd.)

11:35-12:25

Poster Session 3

12:35-13:30

Luncheon seminar
(sponsored)

Tubulo-glomerular communication and renal protective effects by SGLT2 in diabetic nephropathy

Speaker: Shu Wakino (Japan)

Chair: Takashi Wada (Japan)

(co-sponsored by Mitsubishi Tanabe Pharma Corporation)